{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:41:45Z","timestamp":1791942105548,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Measurements of plasma or urinary metanephrines are recommended for diagnosis of pheochromocytoma and paraganglioma (PPGL). What test offers optimal diagnostic accuracy for patients at high and low risk of disease, whether urinary free metanephrines offer advantages over deconjugated metanephrines, and what advantages are offered by including methoxytyramine in panels all remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>A population of 2056 patients with suspected PPGLs underwent prospective screening for disease using mass spectrometric-based measurements of plasma free, urinary deconjugated, and urinary free metanephrines and methoxytyramine. PPGLs were confirmed in 236 patients and were excluded in others on follow-up evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Measurements of plasma free metabolites offered higher (P &amp;lt; 0.01) diagnostic sensitivity (97.9%) than urinary free (93.4%) and deconjugated (92.9%) metabolites at identical specificities for plasma and urinary free metabolites (94.2%) but at a lower (P &amp;lt; 0.005) specificity for deconjugated metabolites (92.1%). The addition of methoxytyramine offered little value for urinary panels but provided higher (P &amp;lt; 0.005) diagnostic performance for plasma measurements than either urinary panel according to areas under ROC curves (0.991 vs 0.972 and 0.964). Diagnostic performance of urinary and plasma tests was similar for patients at low risk of disease, whereas plasma measurements were superior to both urinary panels for high-risk patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Diagnosis of PPGLs using plasma or urinary free metabolites provides advantages of fewer false-positive results compared with commonly measured deconjugated metabolites. The plasma panel offers better diagnostic performance than either urinary panel for patients at high risk of disease and, with appropriate preanalytics, provides the test of choice. Measurements of methoxytyramine in urine show limited diagnostic utility compared with plasma.<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2018.291369","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T13:45:15Z","timestamp":1533908715000},"page":"1646-1656","source":"Crossref","is-referenced-by-count":165,"title":["Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites"],"prefix":"10.1093","volume":"64","author":[{"given":"Graeme","family":"Eisenhofer","sequence":"first","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Prejbisz","sequence":"first","affiliation":[{"name":"Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Peitzsch","sequence":"first","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Masjkur","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Rogowski-Lehmann","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Langton","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tsourdi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"Center for Healthy Aging, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"P\u0119czkowska","sequence":"first","affiliation":[{"name":"Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fliedner","sequence":"first","affiliation":[{"name":"First Department of Medicine, University Medical Center Schleswig-Holstein, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Megerle","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J L M","family":"Timmers","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sinnott","sequence":"first","affiliation":[{"name":"Department of Computing and Information, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Central Laboratory, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Januszewicz","sequence":"first","affiliation":[{"name":"Department of Hypertension, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2020022606064991100_B1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"2020022606064991100_B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology clinical practice guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2020022606064991100_B3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2020022606064991100_B4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022606064991100_B5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"2020022606064991100_B6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00313020802579284","article-title":"Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma","volume":"41","author":"Hickman","year":"2009","journal-title":"Pathology"},{"key":"2020022606064991100_B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/EJE-06-0640","article-title":"An analysis of the biochemical diagnosis of 66 pheochromocytomas","volume":"156","author":"d'Herbomez","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2020022606064991100_B8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.EJ14-0384","article-title":"Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma","volume":"62","author":"Kim","year":"2015","journal-title":"Endocr J"},{"key":"2020022606064991100_B9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1373\/clinchem.2003.024703","article-title":"Measurement of plasma free metanephrine and normetanephrine by liquid chromatography\u2013tandem mass spectrometry for diagnosis of pheochromocytoma","volume":"50","author":"Lagerstedt","year":"2004","journal-title":"Clin Chem"},{"key":"2020022606064991100_B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1258\/acb.2009.009153","article-title":"Pilot quality assurance programme for plasma metanephrines","volume":"47","author":"Pillai","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"2020022606064991100_B11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"2020022606064991100_B12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2020022606064991100_B13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11154-007-9055-z","article-title":"Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism","volume":"8","author":"Young","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"2020022606064991100_B14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: Importance of supine sampling under fasting conditions","volume":"80","author":"Darr","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020022606064991100_B15","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1210\/jc.2005-2668","article-title":"Comparison of diagnostic accuracy of urinary free metanephrines VMA, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma","volume":"92","author":"Boyle","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022606064991100_B16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1258\/acb.2008.008180","article-title":"Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection","volume":"46","author":"Whiting","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"2020022606064991100_B17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2013.05.018","article-title":"Urinary free metanephrines and suitability of available quality control material","volume":"424","author":"Davison","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2020022606064991100_B18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/cen.12191","article-title":"Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma","volume":"79","author":"Pamporaki","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020022606064991100_B19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma","volume":"2","author":"Eisenhofer","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"2020022606064991100_B20","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","article-title":"Substantial production of dopamine in the human gastrointestinal tract","volume":"82","author":"Eisenhofer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022606064991100_B21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography\u2013tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"2020022606064991100_B22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2012.12.031","article-title":"Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites","volume":"418","author":"Peitzsch","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2020022606064991100_B23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2016.05.008","article-title":"Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas","volume":"49","author":"Patin","year":"2016","journal-title":"Clin Biochem"},{"key":"2020022606064991100_B24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin Chem"},{"key":"2020022606064991100_B25","doi-asserted-by":"publisher","article-title":"The importance of standardisation of measurement and reference intervals for detection of phaeochromocytoma and paraganglioma (PPGL)","author":"Griffin","DOI":"10.1007\/s11845-018-1756-7"},{"key":"2020022606064991100_B26","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022606064991100_B27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-14-0730","article-title":"Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma","volume":"172","author":"Weismann","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020022606064991100_B28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review","volume":"56","author":"Darr","year":"2017","journal-title":"Endocrine"},{"key":"2020022606064991100_B29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clin Chem"},{"key":"2020022606064991100_B30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision medicine: an update on genotype\/biochemical phenotype relationships in pheochromocytoma\/paraganglioma patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract"},{"key":"2020022606064991100_B31","first-page":"69","article-title":"Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"2020022606064991100_B32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"Lenders","year":"2007","journal-title":"Clin Chem"},{"key":"2020022606064991100_B33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","author":"Sawka","year":"2004","journal-title":"BMC Endocr Disord"},{"key":"2020022606064991100_B34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/acb.2010.010131","article-title":"An audit of management of patients with borderline increased plasma-free metanephrines","volume":"47","author":"Anas","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"2020022606064991100_B35","doi-asserted-by":"publisher","article-title":"The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma","author":"Samsudin","DOI":"10.1177\/0004563218774590"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/11\/1646\/32642978\/clinchem1646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/11\/1646\/32642978\/clinchem1646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T01:29:47Z","timestamp":1661736587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/64\/11\/1646\/5608639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2018.291369","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11,1]]},"published":{"date-parts":[[2018,11,1]]}}}